Figure 3.
Typical photographs of anti-4-HNE antibody-stained aortas in a WKY rat and placebo-, valsartan-, valsartan+amlodipine- and valsartan+cilnidipine-treated SHR-SPs (a). Ratios of the anti-4-HNE-stained area to the total area in the WKY rats and placebo (P)-, valsartan (V)-, valsartan+amlodipine (V+A)- and valsartan+cilnidipine (V+C)-treated SHR-SPs (b). **P<0.01 vs. placebo-treated SHR-SPs. #P<0.05 vs. valsartan-treated SHR-SPs.